Wydra D

No ORCID on file · 5 papers in corpus · active 1996-2026

Study types

  • article 1

Condition tags

  • endometriosis 1
  • dyspareunia 1
2026
Alterations in lipid metabolism and blood profile in gynecological cancers - potential strategies in diagnosis and treatment.
Frontiers in physiology ·doi:10.3389/fphys.2026.1741759

Gynecological cancers (GCs), especially endometrial, cervical and ovarian cancers, represent a major health burden due to their increasing incidence and poor treatment outcomes, particularly in advanced stages. Numerous papers suggest that …

2026
Fertility, Pregnancy, and Psychological Burden in OHVIRA Syndrome: Clinical Case Study and Review of the Literature
Journal of clinical medicine
2022
Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects.
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12112604

Myometrial invasion (MI) is a parameter currently used in transvaginal ultrasound (TVS) in endometrial cancer (EC) to determine local staging; however, without molecular diagnostics, it is insufficient for the selection of high-risk cases, …

2021
Ultrasound Measurement of Tumor-Free Distance from the Serosal Surface as the Alternative to Measuring the Depth of Myometrial Invasion in Predicting Lymph Node Metastases in Endometrial Cancer.
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics11081472

BackgroundUltrasonography's usefulness in endometrial cancer (EC) diagnosis consists in its roles in staging and prediction of metastasis. Ultrasound-measured tumor-free distance from the tumor to the uterine serosa (uTFD) is a promising ma…

article 1996
GnRH analogs in treating uterine leiomyomata and endometriosis.
Clinical and experimental obstetrics & gynecology

The results of hormonal examinations, measurements of dimensions of the uterus and leiomyomas, body weight, and also frequency of incurred climacteric signs in patients treated with Decapeptyl Depot 3.75 mg for three months are reported. Su…